Last updated on February 2019

A Genomic Approach for Clopidogrel in Caribbean Hispanics

Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions: Cerebrovascular accident | Peripheral vascular disease | Acute Coronary Syndrome | Cardiovascular Disease | peripheral arterial disease | Myocardial Infarction | Coronary Artery Disease | Coronary heart disease
  • Age: Between 21 - 100 Years
  • Gender: Male or Female

Inclusion Criteria:

  • Caribbean Hispanics (Puerto Ricans, Dominicans or Cubans) residing in Puerto Rico, whose parents are also of Hispanic origin
  • Both genders (Males/Females)
  • Age 21
  • Receiving Clopidogrel for therapeutic indications.
  • No clinically active hepatic abnormality
  • The ability to understand the requirements of the study
  • The ability to comply with study procedures and protocol
  • A female patient is eligible to enter the study if she is of child-bearing potential and not pregnant or nursing, or not of child-bearing potential

Exclusion Criteria:

  • Non-Hispanic patients (race/ethnicity is self-reported by the patients)
  • Currently enrolled in another active research protocols at the participating institutions
  • BUN >30
  • Creatinine >2.0 mg/dL
  • Platelet count <100,000/mm3
  • Nasogastric or enteral feedings
  • Acute illness (e.g., sepsis, infection, anemia)
  • HIV/AIDS, Hepatitis B patients
  • Alcoholism and drug abuse
  • Patients with any cognitive and mental health impairment
  • Sickle cell patients
  • Active malignancy
  • Patients taking another antiplatelet

Recruitment Status: Open

Brief Description Eligibility Contact Research Team

Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.